Xiaohong Li
Kunming, 650021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
CXCR6 as a novel therapeutic target in allergic asthma.
Journal: International immunopharmacology
Published: September 23, 2025
(±)-Agrimonolide: Efficient synthesis and treatment of inflammatory bowel disease via JAK1/STAT3 pathway inhibition.
Journal: Bioorganic & medicinal chemistry
Published: July 07, 2025
Huatanhuoxue decoction alleviates airway inflammation by regulating IL-17A signaling pathway in obese asthmatic mice.
Journal: Journal of ethnopharmacology
Published: January 27, 2025
Shuteria involucrata alleviates OVA-induced asthma through the TLR4/NF-κB pathway.
Journal: Fitoterapia
Published: January 21, 2025
Involucrasin B suppresses airway inflammation in obese asthma by inhibiting the TLR4-NF-κB-NLRP3 pathway.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: March 08, 2024
Baiheqingjin formula reduces inflammation in mice with asthma by inhibiting the PI3K/AKT/NF-κb signaling pathway.
Journal: Journal of ethnopharmacology
Published: September 27, 2023
CAVO Inhibits Airway Inflammation and ILC2s in OVA-Induced Murine Asthma Mice.
Journal: BioMed research international
Published: September 30, 2022
Therapeutic Effect of Renifolin F on Airway Allergy in an Ovalbumin-Induced Asthma Mouse Model In Vivo.
Journal: Molecules (Basel, Switzerland)
Published: May 23, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026